Royal Cosun
Van de Reijtstraat 15, Breda, North Brabant, 4814 NE, Netherlands
Overview
Royal Cosun produces plant-based ingredients and foodstuffs for people and animals.
- Total investments
- 2
- Lead investments
- 0
- Investments · 12mo
- 2
- Active investors
- 0
Sector focus
- Agriculture
- Farming
- Food and Beverage
- Manufacturing
Investment portfolio
- Planetary
Participated · Series A · Apr 2026
Founded in 2021, Planetary develops and operates a proprietary full-stack platform for bioprocess design, scale-up and industrial fermentation via its BioBlocks system. The company builds, owns and operates fermentation facilities to produce bio-based proteins, fibres and enzymes and pursues an IP-rich licensing strategy with agro-industrial partners, particularly sugar companies. Planetary has commercial traction through product launches under its B2B brand Libre®, including a nationwide mycoprotein filet launch with ALDI Suisse at price parity. It operates industrial-scale production in Aarberg, Switzerland and is scaling sugar-to-protein upcycling technology globally, targeting ultra-low-cost mycoprotein production below €0.85/kg in collaborations with partners in sucrose-rich regions. Planetary is rolling out additional launches across alternative meat and dairy, meat hybrids, fibre-rich products and protein fortification applications. The company plans to expand its global commercial rollout and technology licensing efforts using the newly raised capital.
- Revyve
Participated · Series B · Sep 2025
Revyve develops highly functional yeast proteins that mimic the binding, texturizing and emulsifying properties of eggs in categories such as bakery, sauces, alternative meat and plant-based dairy. The ingredients are promoted as natural, clean-label and price-competitive, helping food manufacturers tackle volatile egg prices, reduce additives and cut CO₂ footprints. In 2024 the company brought a first-of-a-kind production plant in Dinteloord online and, with fresh capital, plans to boost annual output to more than 1,600 tons. Revyve already supplies customers in Europe, the UK, the USA, Canada, Mexico and Australia. Originating from Wageningen University & Research, the firm positions itself as a purpose-driven enabler of the global protein transition. Following its Series B round, Revyve’s cumulative fundraising now exceeds €40 million, providing resources for accelerated commercial rollout and global expansion.
Team
No current team members are available.